Cholangiocarcinoma
Showing NaN - NaN of 30
Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide
Recruiting
- Uterine Cervical Neoplasms
- +10 more
- Pembrolizumab/Vibostolimab Co-Formulation
- +11 more
-
Anchorage, Alaska
- +65 more
Jan 27, 2023
l Science Network of Precision-based Immunotherapy for Primary
Recruiting
- Hepatocellular Carcinoma
- +2 more
-
La Jolla, California
- +6 more
Jan 24, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- +8 more
-
Los Angeles, California
- +5 more
Nov 29, 2022
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Colorectal Cancer, Cholangiocarcinoma Trial in United States (Medtronic pump and Codman catheter, Floxuridine (FUDR),
Active, not recruiting
- Colorectal Cancer
- Cholangiocarcinoma
- Medtronic pump and Codman catheter
- +6 more
-
Basking Ridge, New Jersey
- +6 more
Oct 3, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
-
Grand Rapids, Michigan
- +2 more
Jul 18, 2022
Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)
Recruiting
- Cancer, Metastatic
- +42 more
- Clinical Trial Matching
-
New York, New YorkMassive Bio, Inc
May 21, 2021
Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Esophageal Cancer Trial in Belgium, United States (INCB062079)
Terminated
- Hepatocellular Carcinoma (HCC)
- +5 more
-
Birmingham, Alabama
- +5 more
Jul 13, 2020
Clinical and Histopathologic Characteristics of BAP1 Mutations
Completed
- Malignant Pleural Mesothelioma (MPM)
- +5 more
- tumor specimens
-
Harrison, New York
- +1 more
Jun 30, 2020
Cholangiocarcinoma Trial in Austria, United States (Nab-Paclitaxel and Gemcitabine)
Completed
- Cholangiocarcinoma
- Nab-Paclitaxel and Gemcitabine
-
Denver, Colorado
- +24 more
Sep 5, 2018
Carcinoma of Intrahepatic and Extra-hepatic Biliary System, Carcinoma of Gallbladder, Bile Duct Cancer Trial in United States
Completed
- Carcinoma of Intrahepatic and Extra-hepatic Biliary System
- +3 more
- DKN-01
- +2 more
-
Los Angeles, California
- +8 more
Sep 6, 2018
Cholangiocarcinoma, Pancreatic Cancer Trial in New York (Endoscopic bipolar radiofrequency probe (ENDOHPB))
Terminated
- Cholangiocarcinoma
- Pancreatic Cancer
- Endoscopic bipolar radiofrequency probe (ENDOHPB)
-
New York, New YorkWeill Medical College of Cornell University
Apr 21, 2017
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
Unknown status
- Cholangiocarcinoma
- +13 more
- EUS guided ERCP
-
New York, New York
- +1 more
Feb 16, 2017